Ni Rx Medical Technologies LLC is categorized under Optical Instruments and Apparatus in Brooklyn, NY and active since 2004.
Ni Rx Medical Technologies LLC was established in 2004, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Optical Instruments and Apparatus business, which does work in the B2B market, and is classified as a Optical Instruments and Apparatus, under code number 333314 by the NAICS.
If you are seeking more information, feel free to contact Randall Barbour at the company’s single location by writing to 760 Parkside Avenue # 304, Brooklyn, New York NY 11226 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ni Rx Medical Technologies LLC |
| Contact Person: | Randall Barbour |
| Address: | 760 Parkside Avenue # 304, Brooklyn, New York 11226 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Optical Instruments and Apparatus |
| SIC Code: | 3827 |
| NAICS Code: | 333314 |
| Share This Business: |
Ni Rx Medical Technologies LLC was started in 2004 to provide professional Optical Instruments and Apparatus under the SIC code 3827 and NAICS code 333314. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Randall Barbour for inquiries that concern Ni Rx Medical Technologies LLC by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Ni Rx Medical Technologies LLC can be found at the coordinates as well as the street address 760 Parkside Avenue # 304 in Brooklyn, New York 11226.
For its online presence, you may visit Ni Rx Medical Technologies LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.